Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NTRB - Nutriband Inc


IEX Last Trade
4.12
-0.130   -3.155%

Share volume: 41,979
Last Updated: Fri 30 Aug 2024 09:52:11 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$4.25
-0.13
-3.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
24%
Profitability 0%
Dept financing 8%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
Performance
5 Days
-24.58%
1 Month
-37.42%
3 Months
-19.21%
6 Months
61.26%
1 Year
26.32%
2 Year
3.82%
Key data
Stock price
$4.12
P/E Ratio 
-7.07
DAY RANGE
N/A - N/A
EPS 
-$0.77
52 WEEK RANGE
$1.53 - $9.60
52 WEEK CHANGE
$0.28
MARKET CAP 
45.027 M
YIELD 
N/A
SHARES OUTSTANDING 
11.036 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$25,140
AVERAGE 30 VOLUME 
$24,382
Company detail
CEO: Gareth Sheridan
Region: US
Website: https://nutriband.com/
Employees: 7
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

nutriband inc. is a health and pharmaceutical company based in, oviedo, florida. nutriband's primary focus is on transdermal and topical technologies for product development.

Recent news